BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Conrad MA, Kelsen JR. The Treatment of Pediatric Inflammatory Bowel Disease with Biologic Therapies. Curr Gastroenterol Rep 2020;22:36. [PMID: 32542562 DOI: 10.1007/s11894-020-00773-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Balbale SN, Schäfer WLA, Davis T, Blake SC, Close S, Perry JE, Zarate RP, Ingram MC, Strople J, Johnson JK, Holl JL, Raval MV. Age- and Sex-Specific Needs for Children Undergoing Inflammatory Bowel Disease Surgery: A Qualitative Study. J Surg Res 2022;274:46-58. [PMID: 35121549 DOI: 10.1016/j.jss.2021.12.033] [Reference Citation Analysis]
2 Harmand PO, Solassol J. Thiopurine Drugs in the Treatment of Ulcerative Colitis: Identification of a Novel Deleterious Mutation in TPMT. Genes (Basel) 2020;11:E1212. [PMID: 33081236 DOI: 10.3390/genes11101212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Juillerat P, Grueber MM, Ruetsch R, Santi G, Vuillèmoz M, Michetti P. Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom? Current Research in Pharmacology and Drug Discovery 2022. [DOI: 10.1016/j.crphar.2022.100104] [Reference Citation Analysis]
4 Levine AE, Zheng HB, Suskind DL. Linking Genetic Diagnosis to Therapeutic Approach in Very Early Onset Inflammatory Bowel Disease: Pharmacologic Considerations. Pediatr Drugs. [DOI: 10.1007/s40272-022-00503-4] [Reference Citation Analysis]
5 Geem D, Kugathasan S. It Takes Two to Make It Right: Dual Biologic and Small Molecule Therapy for Treatment-Refractory Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:1361-2. [PMID: 33200791 DOI: 10.1093/ibd/izaa279] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Escherich C, Bötticher B, Harmsen S, Hömberg M, Schaper J, Lorenz MR, Schwarz K, Borkhardt A, Oommen PT. The Growing Spectrum of DADA2 Manifestations—Diagnostic and Therapeutic Challenges Revisited. Front Pediatr 2022;10:885893. [DOI: 10.3389/fped.2022.885893] [Reference Citation Analysis]
7 Michel HK, Boyle B, David J, Donegan A, Drobnic B, Kren C, Maltz RM, McKillop HN, McNicol M, Oates M, Dotson JL. The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model. Inflamm Bowel Dis 2021:izab238. [PMID: 34562013 DOI: 10.1093/ibd/izab238] [Reference Citation Analysis]
8 Wang X, Zhou G, Zhou W, Wang X, Wang X, Miao C. Exosomes as a New Delivery Vehicle in Inflammatory Bowel Disease. Pharmaceutics 2021;13:1644. [PMID: 34683937 DOI: 10.3390/pharmaceutics13101644] [Reference Citation Analysis]
9 Olczyk M, Czkwianianc E, Socha-banasiak A. Metabolic Bone Disorders in Children with Inflammatory Bowel Diseases. Life 2022;12:423. [DOI: 10.3390/life12030423] [Reference Citation Analysis]